title: Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 2: topical therapies.
abstract: In part 1 of this 3-part series, an overview of the epidemiology, visible patterns, and important considerations for clinical and laboratory evaluation of acne vulgaris (AV) in adult women was provided. Proper selection and integration of skin care products is important in the management of AV in this patient population. Part 2 of this series includes a discussion of over-the-counter and prescription topical therapies for adult women with AV. A summary of key randomized controlled trials also is provided. Further well-designed studies are needed, as data on the use of topical agents in this subpopulation are limited.
authors.affiliation: Touro University College of Osteopathic Medicine, Henderson, Nevada, and Las Vegas Dermatology, Nevada, USA.
authors.forename: James Q
authors.initials: JQ
authors.lastname: Del Rosso
authors.affiliation: Private practice, Birmingham, Alabama, USA.
authors.forename: Julie C
authors.initials: JC
authors.lastname: Harper
authors.affiliation: Private practice, Boston, Massachusetts, USA.
authors.forename: Emmy M
authors.initials: EM
authors.lastname: Graber
authors.affiliation: Penn State University Medical Center, Hershey, USA.
authors.forename: Diane
authors.initials: D
authors.lastname: Thiboutot
authors.affiliation: Department of Dermatology, Mount Sinai St. Luke's-Roosevelt and Beth Israel Medical Center of the Icahn School of Medicine at Mount Sinai, New York, New York, USA.
authors.forename: Nanette B
authors.initials: NB
authors.lastname: Silverberg
authors.affiliation: University of California, San Diego School of Medicine, USA and Rady Children's Hospital, San Diego, California, USA.
authors.forename: Lawrence F
authors.initials: LF
authors.lastname: Eichenfield
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy* / Q000473:pathology; D000279:Administration, Cutaneous; D000328:Adult; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D004366:Nonprescription Drugs / Q000008:administration & dosage / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012955:Societies, Medical; D014481:United States
chemical_list: D003879:Dermatologic Agents; D004366:Nonprescription Drugs